Literature DB >> 7913712

Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.

M Maruyama1, J G Hay, K Yoshimura, C S Chu, R G Crystal.   

Abstract

Secretory leukoprotease inhibitor (SLPI), a 12-kD nonglycosylated serine antiprotease, helps to protect the epithelial surface of the airways from the destructive capacity of neutrophil elastase. Based on the recognition that SLPI levels can increase in the presence of airway inflammation, we hypothesized that inflammatory stimuli should modulate the expression of the SLPI gene in airway epithelial cells. To evaluate this, the modulation of SLPI gene expression with various inflammatory stimuli was evaluated in the HS-24 human bronchial epithelial cell line. After preliminary studies showed that several inflammatory mediators enhanced SLPI messenger RNA (mRNA) levels, PMA was used as a model inflammatory stimulus. PMA significantly increased the level of 0.7-kb SLPI mRNA transcripts in HS-24 cells in a dose- and time-dependent fashion and increased the amount of SLPI protein in the culture supernatant. Nuclear run-on analyses showed that the SLPI gene transcription rate increased approximately twofold after PMA stimulation. Transfection studies using fusion genes composed of fragments of up to 1.2 kb of the 5' flanking sequence of the SLPI gene and a luciferase reporter gene demonstrated potent promoter activity in the 131-bp segment (-115 to +16 relative to the transcription start site), and all longer segments up to 1.2 kb, whereas smaller segments showed low promoter activity. An 18-bp element (-98 to -115), in a region with homology to PMA-responsive regions in the Moloney murine leukemia virus enhancer and the IL-8 gene, was shown to be of importance in the level of transcription of the SLPI gene. However, this element was not responsible for the upregulation of SLPI gene expression by PMA. Evaluation of HS-24 cells in the presence of actinomycin D demonstrated that SLPI mRNA transcripts were very stable and became more so in the presence of PMA. Thus, SLPI gene expression in airway epithelial cells can be upregulated by an inflammatory stimulus, and this modulation is regulated at both the transcriptional and posttranscriptional levels. These mechanisms of SLPI upregulation likely play a role in defending the epithelial surface in the local milieu of inflammatory lung diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913712      PMCID: PMC296318          DOI: 10.1172/JCI117331

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  61 in total

1.  Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP.

Authors:  M Imagawa; R Chiu; M Karin
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases.

Authors:  G Stetler; M T Brewer; R C Thompson
Journal:  Nucleic Acids Res       Date:  1986-10-24       Impact factor: 16.971

4.  Secretion of antileucoprotease from a human lung tumor cell line.

Authors:  B Appelhans; B Ender; G Sachse; T Nikiforov; H Appelhans; W Ebert
Journal:  FEBS Lett       Date:  1987-11-16       Impact factor: 4.124

5.  Purification of intercalator-released p67, a polypeptide that interacts specifically with the c-fos serum response element.

Authors:  H Schröter; P E Shaw; A Nordheim
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

6.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.

Authors:  P Angel; M Imagawa; R Chiu; B Stein; R J Imbra; H J Rahmsdorf; C Jonat; P Herrlich; M Karin
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

7.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements.

Authors:  W Lee; P Mitchell; R Tjian
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

8.  Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha.

Authors:  O Cromwell; Q Hamid; C J Corrigan; J Barkans; Q Meng; P D Collins; A B Kay
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

9.  Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase.

Authors:  R C Thompson; K Ohlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

10.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

View more
  8 in total

1.  Transcriptional activation of RACTK1 K+ channel gene by apical alkalization in renal cortical collecting duct cells.

Authors:  M Ikeda; M Murata; T Miyoshi; K Tamba; S Muto; M Imai; M Suzuki
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

2.  Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor.

Authors:  F Jin; C F Nathan; D Radzioch; A Ding
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.

Authors:  N K Jana; L R Gray; D C Shugars
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence.

Authors:  Sandrine Nugteren; Sjoerd H den Uil; Pien M Delis-van Diemen; Ytje Simons-Oosterhuis; Dicky J Lindenbergh-Kortleve; Daniëlle H van Haaften; Hein B A C Stockmann; Joyce Sanders; Gerrit A Meijer; Remond J A Fijneman; Janneke N Samsom
Journal:  Sci Rep       Date:  2022-07-16       Impact factor: 4.996

5.  Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis.

Authors:  S Ohlsson; R Falk; J J Yang; K Ohlsson; M Segelmark; J Wieslander
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

6.  Novel distribution of the secretory leucocyte proteinase inhibitor in kidney.

Authors:  S Ohlsson; I Ljungkrantz; K Ohlsson; M Segelmark; J Wieslander
Journal:  Mediators Inflamm       Date:  2001-12       Impact factor: 4.711

7.  Identifying Biomarkers from Transcriptomic Signatures in Renal Allograft Biopsies Using Deceased and Living Donors.

Authors:  Bin Yang; Nicolas Sylvius; Jinli Luo; Cheng Yang; Zhanyun Da; Charlottelrm Crotty; Michael L Nicholson
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

8.  Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis.

Authors:  Sandrine Nugteren; Jeroen A C M Goos; Pien M Delis-van Diemen; Ytje Simons-Oosterhuis; Dicky J Lindenbergh-Kortleve; Daniëlle H van Haaften; Joyce Sanders; Gerrit A Meijer; Remond J A Fijneman; Janneke N Samsom
Journal:  Oncoimmunology       Date:  2020-10-13       Impact factor: 8.110

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.